Jeanny Aragon-Ching
0000-0002-6714-141X
3 papers found
Refreshing results…
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial
Impact of abiraterone on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectives
Missing publications? Search for publications with a matching author name.